Patent ID: 11952376
Assignee: PLIANT THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 50:
51. The compound of claim 49, or a pharmaceutically acceptable salt, stereoisomer, or tautomer thereof, wherein:
R2 is C6-C10 aryl, wherein the C6-C10 aryl is optionally substituted by 1, 2, 3, 4, or 5 independently selected R2d substituents: wherein
at least one R2d is C1-C6 alkyl, wherein the C1-C6 alkyl is optionally substituted by 1, 2, 3, 4, or 5 independently selected 9-5 R4a substituents; and
each R4a is independently halogen, C1-C6 alkyl or OR8.